Tokyo, July 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058332) titled 'Efficacy of Immune Checkpoint Inhibitor Combination Chemotherapy in Patients with Recurrent NSCLC After Durvalumab Consolidation Following Chemoradiotherapy: A Multicenter Retrospective Study' on July 3.
Study Type:
Observational
Primary Sponsor:
Institute - Specified Nonprofit Corporation North East Japan Study Group
Condition:
Condition - Non-small cell lung cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to compare the efficacy and safety of platinum-doublet chemotherapy plus immune checkpoint inhibitors versus platinum-doublet chemoth...